Tag: STEADFAST

vTv reports Alzheimer’s candidate failure

by Selina McKee | Apr 11, 2018 | News | 0

It is looking likely that another late-stage candidate for Alzheimer’s disease will fail to make it past Phase III trials, with vTv Therapeutics’ experimental therapy the latest in a long line to miss its targets.

Horizon hit by Actimimmune fail in Friedrich’s ataxia

by Selina McKee | Dec 9, 2016 | News | 0

Horizon Pharma shares dropped 20 percent after the company pulled the plug a late-stage trial testing Actimmune as a potential therapy Friedreich’s ataxia.